Hyperpituitarism (prolactin secreting pituitary dysfunction) — VA Rating Criteria (38 CFR DC 7916)

The VA rates Hyperpituitarism (prolactin secreting pituitary dysfunction) under Diagnostic Code 7916 at the following tiers: 0%. The minimum 0% rating requires: Note: Evaluate as malignant or benign neoplasm, as appropriate.. The maximum 0% rating requires: Note: Evaluate as malignant or benign neoplasm, as appropriate..

Diagnostic Code 7916 is the VA rating identifier for Hyperpituitarism (prolactin secreting pituitary dysfunction) within 38 CFR 38 CFR § 4.119. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.

The maximum rating for Hyperpituitarism (prolactin secreting pituitary dysfunction) is defined in 38 CFR Part 4 under DC 7916. See the rating tiers above for exact criteria.

Hyperpituitarism (prolactin secreting pituitary dysfunction) is rated under 38 CFR 38 CFR § 4.119, Diagnostic Code 7916. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.

Secondary conditions caused or aggravated by Hyperpituitarism (prolactin secreting pituitary dysfunction) may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.

Service connection for Hyperpituitarism (prolactin secreting pituitary dysfunction) requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.